23 February 2017

    Elementis - Directorate Changes

    Elementis plc (ELM.L) (the "Company"), the FTSE 250 Global Specialty Chemicals
    Company, today announces the following changes to its Board of Directors
    ("Board").

    Change of responsibilities
    Andrew Christie, who will complete 9 years on the Board this Summer and who has
    been Chairman of the Remuneration Committee since October 2013, will be
    stepping down from this role and as a non-executive Director following the
    conclusion of the Annual General Meeting to be held on 25 April 2017.

    Steve Good who has been a non-executive Director since October 2014 will become
    Chairman of the Remuneration Committee on 26 April 2017.

    Andrew Duff, Chairman of Elementis, said: "On behalf of the Board, I would like
    to thank Andrew for his significant contribution to the Company's success over
    the past 9 years, particularly as Chairman of the Remuneration Committee where
    a lot of progress has been made to update our policies in line with market
    practice. His corporate finance expertise and strategic insights have also been
    very valuable to us. I wish him well in his future endeavours."

    Appointment of additional non-executive Director
    Following a review of its structure, the Board has decided to increase its size
    from 7 to 8 members to broaden its international profile and expertise and to
    improve resilience by appointing Dorothee Deuring as a non-executive Director
    with effect from 1 March 2017. She will be a member of the Nomination, Audit
    and Remuneration Committees.

    Dorothee Deuring is a non-executive director of Bilfinger SE, a German listed
    industrial services provider (where she is also a member of its audit
    committee), and Röchling Group SE, a privately owned group processing
    engineering plastics (both since 2016), as well as managing her own corporate
    advisory consultancy serving a number of European clients in the pharma/biotech
    sector. Her previous executive roles included managing director and head of
    Corporate Advisory Group (Europe) at UBS in Zurich, head of M&A chemicals and
    healthcare at a private investment bank in Germany and as a senior executive in
    the corporate finance department at the Roche group.

    Dorothee is an Austrian national and has an MSc. degree in Chemistry from the
    Université Louis Pasteur, Strasbourg, and an MBA from INSEAD.

    Andrew Duff, Chairman of Elementis, said: "Dorothee is an excellent addition to
    the Board and her experience and background will bring new skills and insights
    into our boardroom. I am confident that with her corporate finance expertise
    and broader chemicals sector knowledge, she will make a positive contribution
    to the Board's performance and the quality of its discussions."

    The Company confirms that there are no other matters requiring disclosure in
    relation to listing rule 9.6.13.

    Changes in membership of Board Committees
    Following the appointments of Sandra Boss and Dorothee Deuring this year, the
    Board has carried out a review of the structure and composition of its
    Committees and decided to make a number of changes as set out below. These
    changes will be effective from 26 April 2017:

    Anne Hyland, who is Chairman of the Audit Committee and a member of the
    Remuneration and Nomination Committees, will be standing down as a member of
    the Remuneration Committee.

    Steve Good, who will become Chairman of the Remuneration Committee on 26 April
    2017 and is also a member of the Audit and Nomination Committees, will be
    standing down as a member of the Audit Committee.

    The membership of the Board's Committees on 26 April 2017 will be as follows:

    Audit Committee
    Anne Hyland (Chair), Sandra Boss, Dorothee Deuring and Nick Salmon.

    Remuneration Committee
    Steve Good (Chair), Sandra Boss, Dorothee Deuring and Nick Salmon.

    Nomination Committee
    Andrew Duff (Chair), Sandra Boss, Dorothee Deuring, Steve Good, Anne Hyland and
    Nick Salmon.


    Wai Wong
    Company Secretary
    020 7067 2999